Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Bill & Melinda Gates Foundation
Deal Size : $5.0 million
Deal Type : Funding
Bactolife Receives USD 5 Million in New Funding to Address Gastrointestinal Infections Worldwide
Details : Bactolife™ uses its proprietary Binding Protein™ technology to develop novel biological solutions, strengthening the gut microbiome and helping solve the daunting challenge of antimicrobial resistance development as well as the general burden of infe...
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
August 30, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Bill & Melinda Gates Foundation
Deal Size : $5.0 million
Deal Type : Funding